Publications by authors named "Tetsuya Kitayama"

Claim this Profile
M
Multi-Omics Reveal Antioxidant Effects of Bardoxolone Methyl in the Phase 2 Study of Bardoxolone Methyl in Patients with CKD and Type 2 Diabetes Study.
Kentaro Yoshioka, Hiroto Kaneko, Waka Haruyama, Tetsuro Tomiyama, Atsuko Takami, Tetsuya Kitayama

Kidney360· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Nuclear Factor (Erythroid-Derived 2)-Like 2 Activator TBE-31 Influences Body Weight by Affecting White Adipose Tissue in High Fat Diet-Induced Obesity Mice.
Keigo Tsushida, Kohei Yamasaki, Waka Haruyama, Tetsuya Kitayama

Biol Pharm Bull· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of evocalcet on parathyroid calcium-sensing receptor and vitamin D receptor expression in uremic rats.
Tomohiro Saito, Masahide Mizobuchi, Mariko Sakai, Takehisa Kawata, Tetsuya Kitayama

FASEB J· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evocalcet prevents ectopic calcification and parathyroid hyperplasia in rats with secondary hyperparathyroidism.
Mariko Sakai, Shin Tokunaga, Mika Kawai, Miki Murai, Misaki Kobayashi, Tetsuya Kitayama

PLoS One· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positron emission tomography imaging of renal mitochondria is a powerful tool in the study of acute and progressive kidney disease models.
Satoshi Saeki, Hiroyuki Ohba, Yuko Ube, Kayoko Tanaka, Waka Haruyama, Tetsuya Kitayama

Kidney Int· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The persistent inhibitory properties of saxagliptin on renal dipeptidyl peptidase-4: Studies with HK-2 cells in vitro and normal rats in vivo.
Masako Uchii, Mariko Sakai, Yuhei Hotta, Satoshi Saeki, Naoya Kimoto, Tetsuya Kitayama

J Pharmacol Sci· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac DPP-4 inhibition by saxagliptin ameliorates isoproterenol-induced myocardial remodeling and cardiac diastolic dysfunction in rats.
Junichi Ikeda, Naoya Kimoto, Tetsuya Kitayama, Shunji Kunori

J Pharmacol Sci· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats.
Masako Uchii, Naoya Kimoto, Mariko Sakai, Tetsuya Kitayama, Shunji Kunori

Eur J Pharmacol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats.
Mariko Sakai, Masako Uchii, Kensuke Myojo, Tetsuya Kitayama, Shunji Kunori

Eur J Pharmacol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The L-, N-, and T-type triple calcium channel blocker benidipine acts as an antagonist of mineralocorticoid receptor, a member of nuclear receptor family.
Hiromichi Kosaka, Kazunori Hirayama, Nobuyuki Yoda, Katsutoshi Sasaki, Tetsuya Kitayama

Eur J Pharmacol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Osamu Akizuki, Atsushi Inayoshi, Tetsuya Kitayama, Kozo Yao, Shiro Shirakura

Eur J Pharmacol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QT PRODACT: in vivo QT assay in the conscious dog for assessing the potential for QT interval prolongation by human pharmaceuticals.
Shigeki Toyoshima, Akihiro Kanno, Tetsuya Kitayama, Koji Sekiya, Keiko Nakai

J Pharmacol Sci· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QT PRODACT: in vivo QT assay with a conscious monkey for assessment of the potential for drug-induced QT interval prolongation.
Kentaro Ando, Toshiyasu Hombo, Akihiro Kanno, Hironobu Ikeda, Masakazu Imaizumi, Tetsuya Kitayama

J Pharmacol Sci· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QT PRODACT: sensitivity and specificity of the canine telemetry assay for detecting drug-induced QT interval prolongation.
Hiroyasu Miyazaki, Hiroyuki Watanabe, Tetsuya Kitayama, Masahiro Nishida, Yasuhiro Nishi

J Pharmacol Sci· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis